Marshall Wace, LLP CANTEL MEDICAL Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
N/A
-41,285 Closed
0 $0
Q1 2021

May 17, 2021
BUY
N/A
34,745 Added 531.27%
41,285 $3.3 Million
Q4 2020

Feb 16, 2021
SELL
N/A
-37,038 Reduced 84.99%
6,540 $515,000
Q3 2020

Nov 16, 2020
BUY
N/A
43,578 New
43,578 $1.92 Million
Q2 2020

Aug 13, 2020
SELL
N/A
-6,321 Closed
0 $0
Q1 2020

May 15, 2020
BUY
N/A
6,321 New
6,321 $227,000
Q3 2019

Nov 14, 2019
SELL
N/A
-3,418 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
N/A
2,057 Added 151.14%
3,418 $276,000
Q1 2019

May 14, 2019
SELL
N/A
-101,904 Reduced 98.68%
1,361 $91,000
Q4 2018

Feb 14, 2019
SELL
N/A
-22,402 Reduced 17.83%
103,265 $7.69 Million
Q3 2018

Nov 14, 2018
BUY
N/A
125,667 New
125,667 $11.6 Million
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email